Alexis Bio Logo White Glow.png
New Cover Photo_edited.jpg

New
Medicines
from
New Cells

Alexis Bio Provides Regenerative Medicine Solutions

Alexis Bio is a clinical-stage cell therapy company engineering personalized cells to provide regenerative medicine solutions that treat common and rare diseases. Paul Holzer

Skin Burn Icon.png

Xeno-Skin

®

by Alexis Bio

Lab Photo 1.jpg
Nerves Icon.png

Xeno-Nerve

®

by Alexis Bio

Brain Icon.png

Dopaminergic Neuronal Cell Replacement

for Parkinson's Disease

YEAR

2018

YEAR

2020

YEAR

2021

First FDA

Pre-IND for Live Biotherapeutic Xenogeneic Nerve Transplant

First Live Biotherapeutic Xenotransplant FDA IND Cleared for Human Clinical Trials

First Live Biotherapeutic Xenotransplant to Complete US FDA Phase I Clinical Trial

YEAR

2019

YEAR

2021

First Live Biotherapeutic Xenotransplant to Receive FDA Orphan Drug Designation

GROWING SERIES OF FIRSTS

Learn about our company’s journey